InvestorsHub on MSN
Artivion secures FDA approval for NEXUS aortic arch device, weighs Endospan acquisition
Artivion Inc. (NYSE:AORT) said the U.S. Food and Drug Administration has approved the premarket application for the NEXUS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results